Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENABLE: Long-Term Fampridine in Multiple Sclerosis
NCT01480076Phase 4Completed
- Sponsor
- Biogen
- Start
- Feb 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of fampridine in multiple sclerosis (MS), sponsored by Biogen. Started Feb 2012; status: completed.
02
Drugs
fampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01480076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480076.